Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease

Completed

Conditions studied: Chronic Kidney Disease, Polycystic Kidney, Autosomal Dominant

In brief

The aim of this pilot project is to assess the potential of urine micro-RNAs (miRNA) as biomarkers for characterizing patients with autosomal dominant polycystic kidney disease (ADPKD) compared with patients with other causes of chronic kidney disease.

Key facts

Study ID

NCT01114594

Run by

The Rogosin Institute

People needed

42

Starts

2010-04-01

Expected to finish

2012-04-01

Last updated by the study team

2018-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female subject, 18 years of age or older, with diagnosis of ADPKD or non-PKD-CKD
• If female, not pregnant.
• Willing and able to understand and sign informed consent

You may not qualify if…

• Presenting with any signs or symptoms of an infectious disease
• Bacterial infection determined by urine culture
• Use of systemic steroids within a week prior to screening
• History, physical, or laboratory findings suggestive of any other medical or psychological condition that would, in the opinion of the Principal Investigator, make the candidate ineligible for the study.

Where it is running

• The Rogosin Institute — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.